Sickle ß0-Thalassemia
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| A Phase III Safety and Efficacy Study of L-Glutamine to Treat Sickle Cell Disease or Sickle βo-thalassemia (NCT01179217) | Emmaus Medical, Inc. | 2010-05-01 |
Track Sickle ß0-Thalassemia automatically
Every clearance here is in the API, with alerts when new ones post.